FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014373208> ?p ?o ?g. }

• W2014373208 endingPage "e20067" @default.
• W2014373208 startingPage "e20067" @default.
• W2014373208 abstract "Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guérin (BCG) as a prevention against TB. BCG protects against disseminated disease in the first 10 years of life, but provides a variable protection against pulmonary TB and enhancing boost delivered by recombinant modified vaccinia virus Ankara (rMVA) expressing antigen 85A (Ag85A) of M. tuberculosis is currently in phase IIb evaluation in African neonates. If the newborn's mother is positive for human immunodeficiency virus type 1 (HIV-1), the baby is at high risk of acquiring HIV-1 through breastfeeding. We suggested that a vaccination consisting of recombinant BCG expressing HIV-1 immunogen administered at birth followed by a boost with rMVA sharing the same immunogen could serve as a strategy for prevention of mother-to-child transmission of HIV-1 and rMVA expressing an African HIV-1-derived immunogen HIVA is currently in phase I trials in African neonates. Here, we aim to develop a dual neonate vaccine platform against HIV-1 and TB consisting of BCG.HIVA administered at birth followed by a boost with MVA.HIVA.85A. Thus, mMVA.HIVA.85A and sMVA.HIVA.85A vaccines were constructed, in which the transgene transcription is driven by either modified H5 or short synthetic promoters, respectively, and tested for immunogenicity alone and in combination with BCG.HIVA222. mMVA.HIVA.85A was produced markerless and thus suitable for clinical manufacture. While sMVA.HIVA.85A expressed higher levels of the immunogens, it was less immunogenic than mMVA.HIVA.85A in BALB/c mice. A BCG.HIVA222–mMVA.HIVA.85A prime-boost regimen induced robust T cell responses to both HIV-1 and M. tuberculosis. Therefore, proof-of-principle for a dual anti-HIV-1/M. tuberculosis infant vaccine platform is established. Induction of immune responses against these pathogens soon after birth is highly desirable and may provide a basis for lifetime protection maintained by boosts later in life." @default.
• W2014373208 created "2016-06-24" @default.
• W2014373208 creator A5014239001 @default.
• W2014373208 creator A5043068924 @default.
• W2014373208 creator A5057807377 @default.
• W2014373208 creator A5063864164 @default.
• W2014373208 creator A5078509425 @default.
• W2014373208 creator A5082085590 @default.
• W2014373208 date "2011-05-13" @default.
• W2014373208 modified "2023-10-17" @default.
• W2014373208 title "Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosis" @default.
• W2014373208 cites W1491805413 @default.
• W2014373208 cites W1600851666 @default.
• W2014373208 cites W1607937732 @default.
• W2014373208 cites W1862337937 @default.
• W2014373208 cites W1907618785 @default.
• W2014373208 cites W1976794208 @default.
• W2014373208 cites W1987058037 @default.
• W2014373208 cites W2003084960 @default.
• W2014373208 cites W2003878313 @default.
• W2014373208 cites W2011010911 @default.
• W2014373208 cites W2015752737 @default.
• W2014373208 cites W2026619600 @default.
• W2014373208 cites W2034632615 @default.
• W2014373208 cites W2036133436 @default.
• W2014373208 cites W2037377877 @default.
• W2014373208 cites W2044058829 @default.
• W2014373208 cites W2044812530 @default.
• W2014373208 cites W2048705260 @default.
• W2014373208 cites W2063037576 @default.
• W2014373208 cites W2065461284 @default.
• W2014373208 cites W2067267037 @default.
• W2014373208 cites W2071150424 @default.
• W2014373208 cites W2072369136 @default.
• W2014373208 cites W2075477269 @default.
• W2014373208 cites W2078290231 @default.
• W2014373208 cites W2084449171 @default.
• W2014373208 cites W2084756182 @default.
• W2014373208 cites W2086714454 @default.
• W2014373208 cites W2088233624 @default.
• W2014373208 cites W2089450652 @default.
• W2014373208 cites W2089831872 @default.
• W2014373208 cites W2092234326 @default.
• W2014373208 cites W2094801423 @default.
• W2014373208 cites W2095302830 @default.
• W2014373208 cites W2101423698 @default.
• W2014373208 cites W2109238906 @default.
• W2014373208 cites W2112939215 @default.
• W2014373208 cites W2123643891 @default.
• W2014373208 cites W2128904588 @default.
• W2014373208 cites W2131726410 @default.
• W2014373208 cites W2134919119 @default.
• W2014373208 cites W2135151522 @default.
• W2014373208 cites W2141603824 @default.
• W2014373208 cites W2144613565 @default.
• W2014373208 cites W2147379682 @default.
• W2014373208 cites W2156503894 @default.
• W2014373208 cites W2160473798 @default.
• W2014373208 cites W2247920240 @default.
• W2014373208 doi "https://doi.org/10.1371/journal.pone.0020067" @default.
• W2014373208 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3094449" @default.
• W2014373208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21603645" @default.
• W2014373208 hasPublicationYear "2011" @default.
• W2014373208 type Work @default.
• W2014373208 sameAs 2014373208 @default.
• W2014373208 citedByCount "26" @default.
• W2014373208 countsByYear W20143732082012 @default.
• W2014373208 countsByYear W20143732082013 @default.
• W2014373208 countsByYear W20143732082014 @default.
• W2014373208 countsByYear W20143732082015 @default.
• W2014373208 countsByYear W20143732082016 @default.
• W2014373208 countsByYear W20143732082017 @default.
• W2014373208 countsByYear W20143732082018 @default.
• W2014373208 countsByYear W20143732082019 @default.
• W2014373208 countsByYear W20143732082020 @default.
• W2014373208 countsByYear W20143732082021 @default.
• W2014373208 countsByYear W20143732082023 @default.
• W2014373208 crossrefType "journal-article" @default.
• W2014373208 hasAuthorship W2014373208A5014239001 @default.
• W2014373208 hasAuthorship W2014373208A5043068924 @default.
• W2014373208 hasAuthorship W2014373208A5057807377 @default.
• W2014373208 hasAuthorship W2014373208A5063864164 @default.
• W2014373208 hasAuthorship W2014373208A5078509425 @default.
• W2014373208 hasAuthorship W2014373208A5082085590 @default.
• W2014373208 hasBestOaLocation W20143732081 @default.
• W2014373208 hasConcept C104317684 @default.
• W2014373208 hasConcept C142724271 @default.
• W2014373208 hasConcept C147483822 @default.
• W2014373208 hasConcept C159047783 @default.
• W2014373208 hasConcept C159654299 @default.
• W2014373208 hasConcept C203014093 @default.
• W2014373208 hasConcept C22070199 @default.
• W2014373208 hasConcept C2777975735 @default.
• W2014373208 hasConcept C2778497218 @default.
• W2014373208 hasConcept C2779909307 @default.
• W2014373208 hasConcept C2780868878 @default.
• W2014373208 hasConcept C2781069245 @default.
• W2014373208 hasConcept C2781356689 @default.

• next